Average Co-Inventor Count = 6.88
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (21 from 3,681 patents)
2. Rigel Pharmaceuticals, Incorporated (4 from 488 patents)
3. Other (1 from 832,680 patents)
4. Bristol Meyers Squibb Company (1 from 41 patents)
23 patents:
1. 12454531 - Substituted piperazine derivatives useful as T cell activators
2. 11964973 - Substituted bicyclic compounds useful as T cell activators
3. 11713316 - Substituted naphthyridinone compounds useful as T cell activators
4. 11584747 - Substituted pyridopyrimidinonyl compounds useful as T cell activators
5. 11352360 - TGF-beta inhibitors
6. 10961229 - Selective NR2B antagonists
7. 10961239 - TGF beta receptor antagonists
8. 10954225 - Selective NR2B antagonists
9. 10954238 - Substituted naphthyridinone compounds useful as T cell activators
10. 10669272 - Substituted naphthyridinone compounds useful as T cell activators
11. 10501451 - Selective NR2B antagonists
12. 10399987 - TGF beta receptor antagonists
13. 10344020 - Selective NR2B antagonists
14. 10336761 - TGFβ receptor antagonist
15. 10292985 - TGF beta receptor antagonists